학술논문

Vitamin D3 reduces risk of cardiovascular and liver diseases by lowering homocysteine levels: double-blinded, randomised, placebo-controlled trial.
Document Type
Article
Source
British Journal of Nutrition; 1/28/2020, Vol. 125 Issue 2, p139-146, 8p
Subject
CARDIOVASCULAR disease prevention
LIVER disease prevention
THERAPEUTIC use of vitamin D
ASPARTATE aminotransferase
C-reactive protein
COMPARATIVE studies
CREATININE
GLOMERULAR filtration rate
KIDNEY function tests
LIVER function tests
OBESITY
PLACEBOS
UREA
VITAMIN D deficiency
HOMOCYSTEINE
CHOLECALCIFEROL
ALANINE aminotransferase
RANDOMIZED controlled trials
PRE-tests & post-tests
BLIND experiment
Language
ISSN
00071145
Abstract
Copyright of British Journal of Nutrition is the property of Cambridge University Press and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)